• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌大肠杆菌Nissle 1917菌株对肠道感染猪模型急性分泌性腹泻的预防作用。

Preventive effects of the probiotic Escherichia coli strain Nissle 1917 on acute secretory diarrhea in a pig model of intestinal infection.

作者信息

Schroeder B, Duncker S, Barth S, Bauerfeind R, Gruber A D, Deppenmeier S, Breves G

机构信息

Department of Physiology, School of Veterinary Medicine Hannover, Germany.

出版信息

Dig Dis Sci. 2006 Apr;51(4):724-31. doi: 10.1007/s10620-006-3198-8.

DOI:10.1007/s10620-006-3198-8
PMID:16614995
Abstract

Pretreatment with the probiotic Escherichia colistrain Nissle 1917 (EcN) was assessed in a pig model of intestinal infection to prevent acute secretory diarrhea. In the model 10(10) colony forming units of the porcine enterotoxigenic Escherichia coli Abbotstown (EcA) was given via orogastric tube to weaned piglets at day 21 postpartum (-EcN/+EcA group, n = 7). Forty-eight hours after challenge electrophysiological parameters of isolated intact jejunal epithelia were characterized in Ussing chambers. In agreement with clinical signs of diarrhea, tissues of challenged animals showed an overshoot of secretory response after stimulation of the cAMP-mediated second messenger pathway by forskolin, indicating higher excitability of chloride secretory systems under infected conditions. The data were compared with respective measurements from animals that got a daily dose of 10(10) cfu of the probiotic EcN over 10 days before EcA challenge (+EcN/+EcA group; n = 4), from a group that received only EcN (+EcN/-EcA; n = 4), or from a group that remained totally untreated (-EcN/-EcA; n = 6). EcN pretreatment completely abolished clinical signs of secretory diarrhea in +EcN/+EcA animals. Furthermore, jejunum epithelia of these animals did not exhibit an overshoot of secretory response upon stimulation with forskolin. Our studies demonstrate for the first time the efficacy of prophylactic EcN in pig small intestine for preventing an effect of toxigenic EcA. This infection model with freshly weaned piglets may be predestinated to further characterize EcN effects on the cellular level, i.e., involved second messenger pathways, or it may also be useful to examine the efficacy of other substrates or microbe strains against secretory stimuli.

摘要

在肠道感染的猪模型中评估了用益生菌大肠杆菌Nissle 1917(EcN)进行预处理以预防急性分泌性腹泻的效果。在该模型中,于产后第21天经口胃管给断奶仔猪投喂10¹⁰个猪产肠毒素大肠杆菌Abbotstown(EcA)菌落形成单位(-EcN/+EcA组,n = 7)。攻毒48小时后,在尤斯灌流小室中对分离的完整空肠上皮的电生理参数进行表征。与腹泻的临床症状一致,攻毒动物的组织在通过福司可林刺激cAMP介导的第二信使途径后显示出分泌反应的超调,表明在感染条件下氯分泌系统的兴奋性更高。将这些数据与在EcA攻毒前10天每天给予10¹⁰ cfu益生菌EcN的动物(+EcN/+EcA组;n = 4)、仅接受EcN的组(+EcN/-EcA;n = 4)或完全未处理的组(-EcN/-EcA;n = 6)的相应测量结果进行比较。EcN预处理完全消除了+EcN/+EcA动物分泌性腹泻的临床症状。此外,这些动物的空肠上皮在用福司可林刺激时未表现出分泌反应的超调。我们的研究首次证明了预防性EcN在猪小肠中预防产毒EcA作用的功效。这种用刚断奶仔猪建立的感染模型可能非常适合进一步在细胞水平上表征EcN的作用,即所涉及的第二信使途径,或者它也可能有助于研究其他底物或微生物菌株对分泌刺激的功效。

相似文献

1
Preventive effects of the probiotic Escherichia coli strain Nissle 1917 on acute secretory diarrhea in a pig model of intestinal infection.益生菌大肠杆菌Nissle 1917菌株对肠道感染猪模型急性分泌性腹泻的预防作用。
Dig Dis Sci. 2006 Apr;51(4):724-31. doi: 10.1007/s10620-006-3198-8.
2
Escherichia coli Nissle 1917 Enhances Innate and Adaptive Immune Responses in a Ciprofloxacin-Treated Defined-Microbiota Piglet Model of Human Rotavirus Infection.大肠杆菌 Nissle 1917 增强了环丙沙星治疗的人轮状病毒感染定义微生物组仔猪模型中的先天和适应性免疫反应。
mSphere. 2021 Mar 31;6(2):e00074-21. doi: 10.1128/mSphere.00074-21.
3
Effect of antibiotic, probiotic, and human rotavirus infection on colonisation dynamics of defined commensal microbiota in a gnotobiotic pig model.抗生素、益生菌和人类轮状病毒感染对无菌猪模型中特定共生菌群定植动态的影响。
Benef Microbes. 2018 Jan 29;9(1):71-86. doi: 10.3920/BM2016.0225. Epub 2017 Oct 12.
4
Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection.F1C 菌毛、鞭毛和分泌性细菌成分在益生菌 Escherichia coli Nissle 1917 抑制非典型肠致病性大肠杆菌感染中的作用。
Infect Immun. 2014 May;82(5):1801-12. doi: 10.1128/IAI.01431-13. Epub 2014 Feb 18.
5
Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers.益生菌大肠杆菌Nissle 1917与安慰剂治疗婴幼儿持续时间超过4天的腹泻。
Pediatr Infect Dis J. 2008 Jun;27(6):494-9. doi: 10.1097/INF.0b013e318169034c.
6
Beneficial effects resulting from oral administration of Nissle 1917 on a chronic colitis model.口服 1917 号奈瑟氏菌对慢性结肠炎模型的有益作用。
Benef Microbes. 2020 Dec 2;11(8):779-790. doi: 10.3920/BM2020.0045. Epub 2020 Nov 16.
7
Protective effects of E. coli Nissle 1917 on chickens infected with Salmonella pullorum.大肠杆菌Nissle 1917对感染鸡白痢沙门氏菌的鸡的保护作用。
Microb Pathog. 2022 Nov;172:105768. doi: 10.1016/j.micpath.2022.105768. Epub 2022 Sep 9.
8
Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle.应用消炎痛和大肠杆菌 Nissle 处理的实验猪中的细菌素生成。
World J Gastroenterol. 2011 Feb 7;17(5):609-17. doi: 10.3748/wjg.v17.i5.609.
9
Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo.用于在体内检测益生菌微生物大肠杆菌Nissle 1917菌株(EcN)的绿色荧光蛋白。
J Microbiol Methods. 2005 Jun;61(3):389-98. doi: 10.1016/j.mimet.2005.01.007.
10
Escherichia coli Nissle 1917 administered as a dextranomar microsphere biofilm enhances immune responses against human rotavirus in a neonatal malnourished pig model colonized with human infant fecal microbiota.以葡聚糖微球生物膜形式给予奈瑟氏大肠杆菌 1917 可增强定植有人体婴儿粪便微生物群的新生营养不良猪模型中针对人类轮状病毒的免疫应答。
PLoS One. 2021 Feb 16;16(2):e0246193. doi: 10.1371/journal.pone.0246193. eCollection 2021.

引用本文的文献

1
Antibacterial MccM as the Major Microcin in Nissle 1917 against Pathogenic Enterobacteria.麦考密克菌素 McCM 是 1917 年奈瑟氏菌对抗致病性肠杆菌的主要微菌素。
Int J Mol Sci. 2023 Jul 20;24(14):11688. doi: 10.3390/ijms241411688.
2
Effects of a pre- and probiotic mixture and an autogenous vaccine on growth performance in newly weaned piglets experimentally challenged with an enterotoxigenic strain.益生元和益生菌混合物以及自体疫苗对经产肠毒素菌株实验性攻毒的新断奶仔猪生长性能的影响。
Transl Anim Sci. 2023 Mar 13;7(1):txad030. doi: 10.1093/tas/txad030. eCollection 2023 Jan.
3
Review on Preventive Measures to Reduce Post-Weaning Diarrhoea in Piglets.

本文引用的文献

1
Escherichia coli strain Nissle 1917: significant reduction of neonatal calf diarrhea.大肠杆菌Nissle 1917菌株:显著减少新生犊牛腹泻。
J Dairy Sci. 2005 Jan;88(1):317-23. doi: 10.3168/jds.S0022-0302(05)72690-4.
2
[Distribution of Brachyspira hyodysenteriae and Lawsonia intracellularis in healthy and diarrhoeic pigs].[猪痢疾短螺旋体和胞内劳森菌在健康猪和腹泻猪中的分布]
Berl Munch Tierarztl Wochenschr. 2004 Nov-Dec;117(11-12):493-8.
3
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.
仔猪断奶后腹泻预防措施综述
Animals (Basel). 2022 Sep 27;12(19):2585. doi: 10.3390/ani12192585.
4
Var CNCM I-1079 Reduces Expression of Genes Involved in Inflammatory Response in Porcine Cells Challenged by Enterotoxigenic and Influences Bacterial Communities in an In Vitro Model of the Weaning Piglet Colon.Var CNCM I-1079降低产肠毒素菌攻击的猪细胞中参与炎症反应的基因表达,并在断奶仔猪结肠体外模型中影响细菌群落。
Antibiotics (Basel). 2021 Sep 11;10(9):1101. doi: 10.3390/antibiotics10091101.
5
Escherichia coli Strains Producing Selected Bacteriocins Inhibit Porcine Enterotoxigenic Escherichia coli (ETEC) under both and Conditions.产特定细菌素的大肠杆菌菌株在 和 条件下均能抑制猪肠致病性大肠杆菌(ETEC)。
Appl Environ Microbiol. 2021 Jun 25;87(14):e0312120. doi: 10.1128/AEM.03121-20.
6
High Mobility Group Box 1 and TLR4 Signaling Pathway in Gnotobiotic Piglets Colonized/Infected with , , Nissle 1917 and . Typhimurium.定植/感染 、 、 、 和 的无菌仔猪中高迁移率族蛋白 B1 和 TLR4 信号通路。
Int J Mol Sci. 2019 Dec 13;20(24):6294. doi: 10.3390/ijms20246294.
7
Colonization of Germ-Free Piglets with Commensal , , and Probiotic Nissle 1917 and Their Interference with Typhimurium.用共生菌、[此处原文缺失部分内容]和益生菌Nissle 1917对无菌仔猪进行定殖及其对鼠伤寒沙门氏菌的干扰。
Microorganisms. 2019 Aug 20;7(8):273. doi: 10.3390/microorganisms7080273.
8
The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation.肠道共生菌在增强肠道屏障功能和缓解炎症方面的潜力。
Nutrients. 2018 Jul 29;10(8):988. doi: 10.3390/nu10080988.
9
Structural Modulation of Gut Microbiota during Alleviation of Suckling Piglets Diarrhoea with Herbal Formula.中药配方缓解哺乳仔猪腹泻过程中肠道微生物群的结构调节
Evid Based Complement Alternat Med. 2017;2017:8358151. doi: 10.1155/2017/8358151. Epub 2017 Dec 24.
10
Colonization with Escherichia coli EC 25 protects neonatal rats from necrotizing enterocolitis.大肠杆菌EC 25定殖可保护新生大鼠免受坏死性小肠结肠炎的侵害。
PLoS One. 2017 Nov 30;12(11):e0188211. doi: 10.1371/journal.pone.0188211. eCollection 2017.
使用益生菌大肠杆菌Nissle 1917维持溃疡性结肠炎缓解的效果与使用标准美沙拉嗪相当。
Gut. 2004 Nov;53(11):1617-23. doi: 10.1136/gut.2003.037747.
4
Studies on the time course of the effects of the probiotic yeast Saccharomyces boulardii on electrolyte transport in pig jejunum.关于益生菌酵母布拉氏酵母菌对猪空肠电解质转运影响的时间进程研究。
Dig Dis Sci. 2004 Aug;49(7-8):1311-7. doi: 10.1023/b:ddas.0000037828.05100.52.
5
NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium.大肠杆菌Nissle 1917通过NF-κB和AP-1介导诱导肠上皮细胞中人β-防御素-2:一种益生菌的新作用
Infect Immun. 2004 Oct;72(10):5750-8. doi: 10.1128/IAI.72.10.5750-5758.2004.
6
Animal models of inflammatory bowel disease.炎症性肠病的动物模型。
J Pharmacol Toxicol Methods. 2004 Sep-Oct;50(2):81-92. doi: 10.1016/j.vascn.2003.12.002.
7
Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria.革兰氏阳性和革兰氏阴性益生菌诱导细胞因子的模式。
FEMS Immunol Med Microbiol. 2004 Oct 1;42(2):173-80. doi: 10.1016/j.femsim.2004.04.001.
8
Probiotics and human health: a clinical perspective.益生菌与人类健康:临床视角
Postgrad Med J. 2004 Sep;80(947):516-26. doi: 10.1136/pgmj.2003.008664.
9
Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917.非致病性益生菌大肠杆菌Nissle 1917株的基因组结构分析。
J Bacteriol. 2004 Aug;186(16):5432-41. doi: 10.1128/JB.186.16.5432-5441.2004.
10
Probiotics and the management of inflammatory bowel disease.益生菌与炎症性肠病的管理
Inflamm Bowel Dis. 2004 May;10(3):286-99. doi: 10.1097/00054725-200405000-00018.